Overview
Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma
Status:
Unknown status
Unknown status
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is a randomized Phase III study to evaluate efficancy of weekly cisplatin or nedaplatin concurrent with Intensity-modulated radiation therapy in Nasopharyngeal Carcinoma (NPC).Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
He XiaTreatments:
Cisplatin
Nedaplatin
Criteria
Inclusion Criteria:- Pathologically confirmed untreated NPC patients
- T1-2N1-3M0 or T3-4NxM0
- 18-70 years old
- with MRI examinations
- ECOG ≤ 2
- With written consent
Exclusion Criteria:
- With a second cancer
- Pregnancy
- With other severe diseases (blood,liver ,kidney or heart diseases)
- Could not be staged properly
- Without written consent